Concentra (CON)
Delivers workplace injury care and employer health services through centers, worksites, and telemedicine.
Something off on this page? Send us feedback.
Provides workers' compensation care, physical rehabilitation, workforce screening, testing, and preventive services through U.S. occupational health centers, employer-site clinics, and telemedicine. Revenue is concentrated in the center network, and demand depends on employment activity, workplace injuries, employer relationships, and state reimbursement rules.
Provides occupational health care through stand-alone centers, employer-site clinics, and complementary businesses spanning telemedicine, pharmacy, and substance-testing administration. Core services cover workplace injury treatment and physical rehabilitation, plus employer-paid physicals, drug and alcohol screening, clinical testing, vaccinations, and preventive care. Limited consumer urgent care rounds out the mix.
Runs a national U.S. network that combines local clinical delivery with standardized workflows, employer account tools, and virtual access. Occupational health centers generate most revenue, while onsite clinics serve medium and large employers at their workplaces; all operations are combined in one reportable segment.
Demand follows employment, hiring, employee turnover, and workplace injury volumes. Workers' compensation reimbursement is governed largely by state fee schedules, while clinical operations and health data are subject to state licensing, privacy, and security rules.
Company facts
Target rangeAs of Sep 22, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Aug 11, 2026 | Wells Fargo | Reiterate | Rating: —Target: — | Target: $40 |
| Aug 10, 2026 | Truist Financial | Target | Target: $37 | Target: $42 |
| Aug 10, 2026 | Deutsche Bank | Reiterate | Rating: —Target: $32 | Target: $41 |
| Aug 10, 2026 | Mizuho Securities | Target | Target: — | Target: $40 |
| Jul 14, 2026 | Truist Financial | Target | Target: $29 | Target: $37 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $158.0M · Total debt $2.14B · Total assets $3.01B · Shareholders' equity $477.1M
- Revenue
- $606.0M
- Operating income
- $115.1M
- Net income
- $65.3M
HistoryDividendAnnual yield
| Institutions | 89.17% | 113.71M shares | |
|---|---|---|---|
| 295 holders · as of Jun 30, 2026 | |||
| Insiders | 6.99% | 8.91M shares | |
| 20 holders · as of Sep 1, 2026 | |||
| Other | 3.84% | 4.90M shares | |
| remainder | |||
127.52M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 13.92% | 17.75M | as of Jun 30, 2026 |
Price T Rowe Associates Inc /MD/Institution | 13.89% | 17.72M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 5.35% | 6.82M | as of Jun 30, 2026 |
Robert A. Ortenzio1,2Insiderdirector | 5.21% | 6.65M | filed Sep 1, 2026 |
Vanguard Capital Management LLCInstitution | 4.02% | 5.13M | as of Jun 30, 2026 |
- Robert A. Ortenzio's transaction reports restate only vehicles that traded; the 2026 ownership statement (6.65M) is used instead.
- Robert A. Ortenzio reports a block also reported by Arrowstreet Capital, Limited Partnership; it is counted once, under Arrowstreet Capital, Limited Partnership.
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 3, 2026 | Robert A. Ortenzio | director | −130,000 | $31.84 |
| Jul 1, 2026 | Robert A. Ortenzio | director | −130,000 | $30.50 |
| Jun 1, 2026 | Robert A. Ortenzio | director | −130,000 | $25.00 |
| May 8, 2026 | Robert A. Ortenzio | director | −130,000 | $25.00 |
- HCA Healthcare
Urgent care and occupational medicine overlap via CareNow
- UnitedHealth Group
Overlap in work injury care, employer exams, and testing
- CorVel
Workers' comp claims, clinical, network, and virtual-care overlap
- CVS Health
Retail clinics overlap in employer physicals and screenings
- Labcorp
Employer testing network overlapping drug screens and wellness
- Quest Diagnostics
Employer testing overlap in drug screening and occupational labs
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Concentra | $34.73 | −0.44% | $4.46B | 22.6 | 20.1 | 2.0 | +10.0% |
| HCA Healthcare | $436.27 | −0.42% | $94.85B | 14.7 | 14.3 | 1.2 | +8.7% |
| UnitedHealth Group | $370.35 | −0.70% | $338.69B | 24.0 | 17.4 | 0.8 | +0.4% |
| CorVel | $73.18 | −0.56% | $3.75B | 32.7 | — | 3.8 | +10.7% |
| CVS Health | $86.04 | −1.22% | $111.13B | 23.0 | 10.6 | 0.3 | +7.3% |
| Labcorp | $305.49 | −1.94% | $25.55B | 25.8 | 16.1 | 1.8 | +5.8% |
| Quest Diagnostics | $233.09 | −0.71% | $25.92B | 24.9 | 20.3 | 2.2 | +10.2% |
| Median | 24.5 | 16.1 | 1.5 | +8.0% |